文章摘要

参考文献/References

［1］ Lemos PA, serruys PW,van Domburg RT,et al. Unrestricted utilization of sirolimuseluting stents compared with conventional bare stent implantation in the "real world": The RapamycinEluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry［J］.Circulation, 2004,109(2):190-195.

［2］ Orford JL, Lennon R, Melby S,et al, Frequency and correlates of coronary stent thrombosis in the mordern era: analysis of a single center registry［J］. J Am Coll Cardiol,2002,40(9):1567-1572.

［3］ Jeremias A, Sylvia B, Bridges J,et al. Stent Thrombosis After Successful SirolimusEluting Stent implantation［J］. Circulation, 2004,109(14):1930-1932.

［4］霍勇.中国多中心药物洗脱支架,急性或亚急性血栓的调查［J］.中国介入心脏病学杂志,2005，13(3):131-134.

［5］ Tolleson TR, Newby LK, Karrington RA, et al. Frequency of stent thrombosis after acute coronary syndrome (from the SYMPHONY and 2nd SYMPHONY trials)［J］.Am J Cardiol, 2003,92(3):330-333.

［6］ Crines C, Cox D, Stone G,et al. coronary angioplasty with or without stent implantation for acute myocardial infarction.stent primarg angioplasty in myocardial infarction study group. ［J］.N Engl J Med, 1999,341(26):1949-1956.

［7］ Moussa I, Mario C, Reimers B,et al. Subacute stent thrombosis, in the era of intravascular ultrasoundguided coronary stenting without anticoagulation:frequency, predictors and clinical outcome ［J］. J Am coll cardiol, 1997,29(1):6-12.

［8］ Chieffo A, Bonizzoni E, Orlic D, et al. Intraprocedural stent thrombosis during implantation of sirolimuseluting stents［J］.Circulation, 2004,109(22):2732-2736.

［9］ Cheneau E, Leborgne L, Mintz GS.Predictors of subacute stent thrombosis:results of a systematic intravascular ultrasound study［J］.Circulation, 2003,108(1):43-47.

［10］Wang JC, AucoinBarry D, Manuelian D,et al. Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay ASA［J］.Am J Cardiol,2003,92(12):1492-1494.

［11］Gurbel PA, Bliden KP, Hiatt BL,et al. clopidogrel for coronary stenting:response variability, drug resistance, and the effect of pretreatment platelet reactivity［J］. Circulation, 2003,107(23):2908-2913.

［12］Farb A , Burke AP , Kolodgic FD , et al. Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans［J］.Circulation, 2003,108(15):1701-1706.

［13］Mehta SR, Yusuf S, Peters RJ, et al.Effect of pretreatment with clopidogrel and aspirin followed by longteam therapy in patients undergoing percutaneous coronary intervention: the PCICURE study［J］.Lancet,2001,358(9281):527-533.

［14］Steinhubl SR, Berger PB, Mann JT 3rd,et al.Early and sustained dual oral antiplatelet therapy following percutancous coronary intervention: a randomized comtrolled trial［J］. JAMA, 2002,288(19):2411-2420.

［15］贾国良，郭文怡,李伟杰,等.冠状动脉支架术后不同抗凝药物的疗效观察［J］.心脏杂志,2003,15(1):17-19.

［16］ Muller I,Seyfarth M,Rudiger S,et al.Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement［J］. Heart,2001,85（1）：92-93.

［17］ Angiolillo DJ, FernandezOrtiz A, Bernardo E,et al. High clopidogrel loading dose during coronary stenting:effects on drug response and interindividual variability［J］.Eur Heart J,2004,25(21):1903-1910.

［18］韩雅玲，王守力，李毅,等。急性冠状动脉综合征患者冠状动脉支架术前高负荷量氯吡格雷预治疗近期疗效［J］.中国介入心脏病学杂志,2005，13（1）：9-12.

［19］ Hochholzer W, Trenk D, Frundi D ,et al. Time dependence of platelet inhibition after a 600mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention［J］.Circulation,2005,111（22）:2560-2564.

［20］ Moliterno DJ, Yakubov SJ,Dibattiste PM,et al.Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization with stent placement: the TARGET followup study［J］.Lancet, 2002,360(9330):355-360.

我们的网站为什么显示成这样？

支架内血栓形成的原因及防治(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics